CEBP  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gotay, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gotay, C. C.
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 1097-1099, October 2001
© 2001 American Association for Cancer Research


Short Communication

Perceptions of Informed Consent by Participants in a Prostate Cancer Prevention Study1

Carolyn Cook Gotay2

University of Hawai‘i, Cancer Research Center of Hawai‘i, Honolulu, Hawaii 96813

This study examined perceptions of the informed consent process in healthy men participating in a cancer prevention clinical trial. Specifically, we examined influence of the consent form on participation and understanding, adequacy of the consent process in preparing participants for trial experiences, and perceived needs for additional follow-up strategies. Participants (n = 69) enrolled in the Prostate Cancer Prevention Trial at our institution completed mailed questionnaires ~2 years after joining the study. Results indicated that many participants had no remembrance of the consent process, and only a minority reported that the consent process had helped in decision-making about study participation. Eleven men (16%) reported experiencing unexpected study side effects, most related to sexual functioning. Most men (78%) did not feel that they currently needed more information about the study, although virtually all of the respondents wanted to learn the study results. Almost one-third wished to interact with other Prostate Cancer Prevention Trial participants. Results indicate that a signed consent form and initial counseling for a prevention study does not ensure that participants feel they are adequately informed about the study or the side effects. Providing and reinforcing information on a regular and continuous basis is especially important in studies where compliance is required over a period of years.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. M. Ford, J. S. Evans, E. M. Stoffel, J. Balmana, M. M. Regan, and S. Syngal
Factors associated with enrollment in cancer genetics research.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1355 - 1359.
[Abstract] [Full Text] [PDF]


Home page
Clin TrialsHome page
P. Guarino, D. Elbourne, J. Carpenter, and P. Peduzzi
Consumer involvement in consent document development: a multicenter cluster randomized trial to assess study participants' understanding
Clinical Trials, February 1, 2006; 3(1): 19 - 30.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.